chitosan has been researched along with sulfasalazine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, T; Muranishi, S; Odoriba, T; Okabe, S; Terabe, A; Tozaki, H; Yamamoto, A | 1 |
Barralet, J; Cerruti, M; Lerouge, S; Samaei, S; Stevenson, MM; Tam, M; Xu, J | 1 |
Du, Q; Li, H; Tang, B; Tang, P; Wu, D; Xu, K; Yang, H | 1 |
Abbasi, S; Ghaffari, S; Safa, N | 1 |
Deng, S; Deng, Y; Hu, Y; Huang, J; Jin, H; Liao, Z; Liu, Y; Lovell, JF; Meng, J; Tian, Y; Tuo, Z; Yang, K; Yang, X; Zhou, Z | 1 |
5 other study(ies) available for chitosan and sulfasalazine
Article | Year |
---|---|
Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Chitin; Chitosan; Colitis; Colon; Disease Models, Animal; Drug Carriers; Male; Mesalamine; Models, Biological; Rats; Rats, Wistar; Reproducibility of Results; Sulfasalazine; Trinitrobenzenesulfonic Acid | 1999 |
Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
Topics: Adhesives; Animals; Body Weight; Catechols; Chitosan; Colitis, Ulcerative; Colon; Dose-Response Relationship, Drug; Drug Delivery Systems; Hydrogels; Mice; Mucins; Occult Blood; Rectum; Sulfasalazine; Tumor Necrosis Factor-alpha | 2017 |
Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release.
Topics: beta-Cyclodextrins; Chitosan; Delayed-Action Preparations; Drug Carriers; Nanoparticles; Particle Size; Sulfasalazine | 2017 |
Porous Silica as Drug Carrier for Controlled Delivery of Sulfasalazine: The Effect of Alginate-N, O-Carboxymethyl Chitosan Gel Coating and Amine Functionalization.
Topics: Alginates; Amines; Chitosan; Drug Carriers; Drug Delivery Systems; Hydrogen-Ion Concentration; Porosity; Silicon Dioxide; Sulfasalazine | 2023 |
Ferroptosis-Enhanced Immunotherapy with an Injectable Dextran-Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma.
Topics: Ascites; Carcinoma, Hepatocellular; Chitosan; Dextrans; Ferroptosis; Humans; Hydrogels; Immunotherapy; Liver Neoplasms; Sulfasalazine | 2023 |